Home > Healthcare > Biotechnology > Biotechnology R&D > Rat Model Market

Rat Model Market Share

Report ID: GMI4165
Published Date: Apr 2022
Report Format: PDF

Download Free Sample

Rat Model Market Share

Some of the major market players operating in the rat model industry are:

Charles River
Envigo
genOway
Biomere
Janvier Labs
Taconic Biosciences, Inc

Major players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations in order to garner maximum revenue share and promote company growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global rat model industry is expected to surpass USD 2.3 billion by 2028 and is poised to record a 7.6% CAGR through 2028 owing to the increasing consumption of personalized medicine and rise in the number of clinical trials.

The share of the inbred rat model market was valued at over USD 368 million in 2021 and will grow with increasing application in the study of a broad variety of human diseases comprising cancer research and neurodegenerative disorders.

The rat model industry size from the companies end-use segment crossed USD 862 million in 2021 and will expand through 2028 driven by heavy R&D investments by pharmaceutical & biotechnology companies.

The rat model industry size from the research & development application segment is anticipated to be valued at over USD 1,648 million by 2028 on account of the increasing number of research & development projects.

The CRISPR technology segment in the rat model market was worth USD 447 million in 2021 and will see expansion due to the rise in the development of transgenic rats for demonstrating unprecedented safety, efficiency, and easy applicability.

The rat model industry in the U.S. is set to reach a revenue of over USD 1,589 million by 2028 due to the surging demand for personalized medication and the jump in research activities in drug development.